Literature DB >> 31187350

Electroacupuncture inhibits visceral pain via adenosine receptors in mice with inflammatory bowel disease.

Tengfei Hou1, Hongchun Xiang1, Lingling Yu2, Wen Su3, Yang Shu4, Hongping Li1, He Zhu1, Lixue Lin1, Xuefei Hu1, Shangdong Liang5, Hong Zhang6, Man Li7.   

Abstract

To investigate the involvement of peripheral adenosine receptors in the effect of electroacupuncture (EA) on visceral pain in mice with inflammatory bowel disease (IBD). 2,4,6-Trinitrobenzene sulfonic acid (TNBS) was used to induce the visceral pain model. EA (1 mA, 2 Hz, 30 min) treatment was applied to bilateral acupoints "Dachangshu" (BL25) 1 day after TNBS injection once daily for 7 consecutive days. Von Frey filaments were used to measure the mechanical pain threshold. Western blot was used to detect the protein expression levels of adenosine 1 receptor (A1R), adenosine 2a receptor (A2aR), adenosine 2b receptor (A2bR), adenosine 3 receptor (A3R), substance P (SP), and interleukin 1 beta (IL-1β) in colon tissue. EA significantly ameliorated the disease-related indices and reduced the expression of SP and IL-1β in the colon tissues of mice with IBD. EA increased the expression of A1R, A2aR, and A3R and decreased the expression of A2bR in the colon tissue. Furthermore, the administration of adenosine receptor antagonists influenced the effect of EA. EA can inhibit the expression of the inflammatory factors SP and IL-1β by regulating peripheral A1, A2a, A2b, and A3 receptors, thus inhibiting visceral pain in IBD mice.

Entities:  

Keywords:  Adenosine receptor; Electroacupuncture (EA); Inflammatory bowel disease (IBD); Visceral pain

Mesh:

Substances:

Year:  2019        PMID: 31187350      PMCID: PMC6657407          DOI: 10.1007/s11302-019-09655-4

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  50 in total

1.  Differential gene expression of adenosine A1, A2a, A2b, and A3 receptors in the human enteric nervous system.

Authors:  F L Christofi; H Zhang; J G Yu; J Guzman; J Xue; M Kim; Y Z Wang; H J Cooke
Journal:  J Comp Neurol       Date:  2001-10-08       Impact factor: 3.215

2.  Structural studies of the serotype-f polysaccharide antigen from Streptococcus mutans OMZ175.

Authors:  R Linzer; M S Reddy; M J Levine
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

Review 3.  International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.

Authors:  Bertil B Fredholm; Adriaan P IJzerman; Kenneth A Jacobson; Joel Linden; Christa E Müller
Journal:  Pharmacol Rev       Date:  2011-02-08       Impact factor: 25.468

4.  ADOA3R as a therapeutic target in experimental colitis: proof by validated high-density oligonucleotide microarray analysis.

Authors:  Jorge Guzman; Jun Ge Yu; Zacharias Suntres; Andrey Bozarov; Helen Cooke; Najma Javed; Herbert Auer; Jeff Palatini; Hamdy H Hassanain; Arturo J Cardounel; Asad Javed; Iveta Grants; Jacqueline E Wunderlich; Fievos L Christofi
Journal:  Inflamm Bowel Dis       Date:  2006-08       Impact factor: 5.325

5.  Preventive effects of cranberry products on experimental colitis induced by dextran sulphate sodium in mice.

Authors:  Xiao Xiao; Jonggun Kim; Quancai Sun; Daeyoung Kim; Cheon-Seok Park; Tzong-Shi Lu; Yeonhwa Park
Journal:  Food Chem       Date:  2014-07-09       Impact factor: 7.514

6.  Intrathecal adenosine analog administration reduces substance P in cerebrospinal fluid along with behavioral effects that suggest antinociception in rats.

Authors:  K F Sjölund; A Sollevi; M Segerdahl; T Lundeberg
Journal:  Anesth Analg       Date:  1997-09       Impact factor: 5.108

7.  Involvement of the adenosine A1 and A2A receptors in the antidepressant-like effect of zinc in the forced swimming test.

Authors:  Kelly R Lobato; Ricardo W Binfaré; Josiane Budni; Angelo Oscar Rosa; Adair Roberto S Santos; Ana Lúcia S Rodrigues
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-01-26       Impact factor: 5.067

8.  Quantitative assessment of tactile allodynia in the rat paw.

Authors:  S R Chaplan; F W Bach; J W Pogrel; J M Chung; T L Yaksh
Journal:  J Neurosci Methods       Date:  1994-07       Impact factor: 2.390

9.  Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitis.

Authors:  Julia-Stefanie Frick; Christopher F MacManus; Melanie Scully; Louise E Glover; Holger K Eltzschig; Sean P Colgan
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

10.  [Effect of Electroacupuncture and Manual Acupuncture on Colonic Inflammatory Injury, Cytokine Levels and Cell Apoptosis in Ulcerative Colitis Rats].

Authors:  Li-Wei Shi; Han Gu; Ming-Jiang Liu; Jin-Gui Li; Xin Zhao; Jin-Ying Jiao; Nan Cheng
Journal:  Zhen Ci Yan Jiu       Date:  2017-02-25
View more
  10 in total

1.  Spinal cord astrocyte P2X7Rs mediate the inhibitory effect of electroacupuncture on visceral hypersensitivity of rat with irritable bowel syndrome.

Authors:  Zhi-Jun Weng; Shi-Xiu Hu; Fang Zhang; Zhi-Ying Zhang; Yun Zhou; Min Zhao; Yan Huang; Yu-Hu Xin; Huan-Gan Wu; Hui-Rong Liu
Journal:  Purinergic Signal       Date:  2022-04-07       Impact factor: 3.765

2.  The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A3 Receptor Agonist, in a Rat Model of Colitis.

Authors:  Luca Antonioli; Elena Lucarini; Catia Lambertucci; Matteo Fornai; Carolina Pellegrini; Laura Benvenuti; Lorenzo Di Cesare Mannelli; Andrea Spinaci; Gabriella Marucci; Corrado Blandizzi; Carla Ghelardini; Rosaria Volpini; Diego Dal Ben
Journal:  Cells       Date:  2020-06-21       Impact factor: 6.600

3.  Electroacupuncture Alleviates Paclitaxel-Induced Peripheral Neuropathic Pain in Rats via Suppressing TLR4 Signaling and TRPV1 Upregulation in Sensory Neurons.

Authors:  Yuanyuan Li; Chengyu Yin; Xiaojie Li; Boyu Liu; Jie Wang; Xiaoli Zheng; Xiaomei Shao; Yi Liang; Junying Du; Jianqiao Fang; Boyi Liu
Journal:  Int J Mol Sci       Date:  2019-11-25       Impact factor: 5.923

Review 4.  Control of Gut Inflammation by Modulation of Purinergic Signaling.

Authors:  Marta Vuerich; Samiran Mukherjee; Simon C Robson; Maria Serena Longhi
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

Review 5.  Tribute to Prof. Geoffrey Burnstock: his contribution to acupuncture.

Authors:  Yong Tang; Peter Illes
Journal:  Purinergic Signal       Date:  2020-10-09       Impact factor: 3.765

6.  P2Y12 receptor as a new target for electroacupuncture relieving comorbidity of visceral pain and depression of inflammatory bowel disease.

Authors:  Yanzhen Li; Hong Zhang; Jingwen Yang; Muouyang Zhan; Xuefei Hu; Yongmin Liu; Lingling Yu; Xiaochen Yan; Shangdong Liang; Ruyue Zhang; Ying Lu; Beining Li; Cunzhi Liu; Man Li
Journal:  Chin Med       Date:  2021-12-20       Impact factor: 5.455

7.  Electroacupuncture Reduces Visceral Pain Via Cannabinoid CB2 Receptors in a Mouse Model of Inflammatory Bowel Disease.

Authors:  Hong Zhang; Wei He; Xue-Fei Hu; Yan-Zhen Li; Yong-Min Liu; Wen-Qiang Ge; Ou-Yang Zhanmu; Chao Chen; Yu-Ye Lan; Yang-Shuai Su; Xiang-Hong Jing; Bing Zhu; Hui-Lin Pan; Ling-Ling Yu; Man Li
Journal:  Front Pharmacol       Date:  2022-03-25       Impact factor: 5.810

8.  Upregulated adenosine 2A receptor accelerates post-infectious irritable bowel syndrome by promoting CD4+ T cells' T helper 17 polarization.

Authors:  Li-Wei Dong; Zhi-Chao Ma; Jiao Fu; Bai-Li Huang; Fu-Jin Liu; Deming Sun; Cheng Lan
Journal:  World J Gastroenterol       Date:  2022-07-07       Impact factor: 5.374

9.  Inflammatory Bowel Diseases: It's Time for the Adenosine System.

Authors:  Luca Antonioli; Matteo Fornai; Carolina Pellegrini; Lorenzo Bertani; Zoltan H Nemeth; Corrado Blandizzi
Journal:  Front Immunol       Date:  2020-07-29       Impact factor: 7.561

10.  CBS-Induced H2S Generation in Hippocampus Inhibits EA-Induced Analgesia.

Authors:  Wen-Jing Ren; Jia Fu; Hai-Yan Yin; Neng-Gui Xu; Chun-Zhi Tang; Li-Zhou Liu; Shu-Guang Yu; Yong Tang
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-29       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.